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A National Quality Improvement Collaborative for
the clinical use of outcome measurement in
specialised mental healthcare: results from a
parallel group design and a nested cluster
randomised controlled trial
Margot J. Metz, Marjolein A. Veerbeek, Gerdien C. Franx, Christina M. van der Feltz-Cornelis,
Edwin de Beurs and Aartjan T. F. Beekman
Background
Although the importance and advantages of measurement-
based care in mental healthcare are well established,
implementation in daily practice is complex and far from
optimal.
Aims
To accelerate the implementation of outcome measurement in
routine clinical practice, a government-sponsored National
Quality Improvement Collaborative was initiated in Dutch-
specialised mental healthcare.
Method
To investigate the effects of this initiative, we combined a
matched-pair parallel group design (21 teams) with a cluster
randomised controlled trial (RCT) (6 teams). At the beginning
and end, the primary outcome ‘actual use and perceived
clinical utility of outcome measurement’ was assessed.
Results
In both designs, intervention teams demonstrated a significant
higher level of implementation of outcome measurement than
control teams. Overall effects were large (parallel group d=0.99;
RCT d=1.25).
Conclusions
The National Collaborative successfully improved the use of
outcome measurement in routine clinical practice.
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Measurement-based care (MBC)1,2 has beneficial effects on achiev-
ing response and remission of mental health disorders, such
as depression.1–6 In addition, MBC can enhance effective commu-
nication between patients and clinicians and involvement of
patients in clinical decision-making.1,5,7–9 Despite these promising
prospects of MBC, the progress in the application of outcome
measurement in routine mental healthcare is slow,10,11 because of
the complexity of its implementation.12–16
To promote outcome measurement in routine clinical practice
in Dutch-specialised mental healthcare, a government-sponsored
National Quality Improvement Collaborative (QIC) was ini‐
tiated.17–20 This National Collaborative gives the unique opportu-
nity to investigate the actual use of outcomemeasurement in clinical
practice and assess the perceived utility of this so-called routine
outcome monitoring (ROM).5,9,14,21 The results of this evaluation
study, conducted within this National Collaborative, are presented
in this paper.
Method
Study design
This evaluation study, conducted within the National ROM QIC,
aimed at accelerating the implementation of ROM in clinical
practice (for details see ‘Intervention’). The study included a
parallel group design with matched pairs of participating teams, in
which a cluster randomised controlled trial (RCT) was embedded
(Fig. 1). In both groups, we investigated the primary outcome: the
actual use of ROM in clinical practice and the perceived clinical
utility of outcome measurement. In addition, we tested whether
there were differences among three groups of clinicians (physicians,
psychologists and nurses).
The participating specialised mental healthcare providers were
each requested to enrol two similar teams. In total, 21 intervention
teams across the country participated in the Collaborative and
survey. Fourteen of them had a matched control team from the
same provider, treating the same patient group (age, diagnosis
and setting) in the same geographical catchment area. Of the 14
matched pairs, 6 pairs were randomly and 8 were non-randomly
assigned to either the intervention or the control condition.
The randomisation of six matched pairs was conducted by an
independent data manager20 (Dutch Trial Register, NTR5262)
(Fig. 1). The 14 control teams conducted ROM ‘as usual’ and
implemented the best practice, only after the end of the study.
In the teams not participating in the RCT, the participating
mental health organisations were allowed to choose which of
their two parallel teams was assigned to the experimental arm of
the study and which was assigned to the control condition. Both
teams were treating similar patient groups in the same geogra-
phical catchment area, just as the matched pairs of the rando-
mised teams. In this paper, we present the results of the parallel
group design and the nested RCT.
The teams consisted of three groups of clinicians: physicians,
psychologists and nurses. The exact multidisciplinary composition
depended on the patient group to be treated (i.e. nurses typically
work in chronic care and psychologists in short-term curative
out-patient treatment). For the study, no patient involvement was
required; thus, no informed consent was needed.
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Intervention: National ROM QIC
The Collaborative promoted the routine use of clinical outcome
questionnaires or rating scales at the beginning, during and at the
end of the treatment. Clinicians were asked to discuss the ROM
results with their patients to guide treatment decisions jointly.
To help implement this ROM practice, the participating teams
followed a National QIC programme of 1-year duration. A QIC
is a multifaceted implementation strategy.17–19 It comprised a mix
of improvement methods, applied both nationally and locally (in
the teams). Conference days, training and booster sessions for
exchange and learning, with experts and patient representatives
present, were important national components of the improvement
strategy. Moreover, the local teams, with involvement of patient
representatives and supported by their management, determined
their own improvement plans, specified in goals, actions and
indicators. The multidisciplinary local teams organised meetings
at their own location to work on their improvement plans. The
teams planned, implemented, evaluated and adjusted their plans
to improve the application of ROM in clinical practice in Plan-
Do-Check-Act cycles.19,22,23 After the Collaborative’s ending, the
control teams are all offered the intervention.
Measurements: primary outcome
The primary outcome, the actual use and perceived clinical utility of
ROM in clinical practice, was assessed by a survey24 for clinicians
at two moments: at the beginning (T0) and at the end (T1) of the
QIC (after 1 year). Data collection took place independent of the
Collaborative, by a data management team. Clinicians were invited
and received a reminder by email to fill out the survey. The results
were processed anonymously, and respondents were only labelled
by team.
The survey had previously been developed by the Trimbos
Institute, Netherlands Institute of Mental Health and Addiction.24
Commissioned by the Ministry of Health, Welfare and Sport, the
survey aims to identify the degree of implementation of ROM. The
items of the survey were based on a systematic literature search
of studies into influencing factors to ROM implementation and
on expert meetings that assessed and rated the relevance of the
identified factors. After a pilot test among clinicians, this develop-
ment process resulted in a survey with 22 statements measuring the
use of ROM in clinical practice from the perspective of the clinician.
All statements had five response categories, ranging from ‘strongly
disagree’ (score 1) to ‘strongly agree’ (score 5). A higher score
meant a better implementation and use of ROM in clinical
practice.24 Exploratory factor analysis demonstrated a four-factor
structure of the instrument:
. Individual use and perceived utility of ROM in daily practice,
consisting of eight items, for example ‘I use the ROM scores to
evaluate the course of treatment’
. Use of ROM in the team and organisational preconditions
(seven items), for example ‘ROM scores are used in multi-
disciplinary consultations’
. Usefulness of the ROM questionnaires (four items), for
example ‘The questionnaires are suitable for measuring
change’
. Accessibility of ROM for patient and clinician (three
items), for example ‘The output of ROM is simple and
attractive’
In addition, a total scale score is calculated by summing all the
items. The internal consistency of the total scale and the domain
‘Individual use and perceived utility of ROM in daily practice’ is
very good, respectively, α=0.93 and α=0.91. The Cronbach’s alphas
of the two other domains are good: ‘Use of ROM in the team and
organisational preconditions’ α=0.86 and ‘Usefulness of the ROM
questionnaires’ α=0.86. The internal consistency of the domain
‘Accessibility ROM for patient and clinician’ is less adequate
(α=0.51). However, this scale was maintained in the survey, first
because of the importance of the content of these items. According
to implementation literature1,5,12,14,16,21 and experiences in the
intervention teams, the accessibility of ROM results for patients
and clinicians is an important precondition in using ROM in
clinical practice (i.e. giving feedback on outcome data to patients
and clinicians, communicating about the results, validating and
using the information for (changes in) treatment plans). Second, a
Cronbach’s alpha >0.5 is deemed just acceptable, with a minimum
of three items contributing to the domain.25
Statistical analysis
Analysis was performed on the four subdomains of the survey and
the total scale score. Data were analysed by SPSS for Windows,
version 22. First, the number of teams, the number of drop-outs of
the study, response to the survey and the composition of teams who
responded to the survey, were described. Chi-squared tests were used
to test potential differences in the composition of teams between the
intervention and control groups. To calculate differences between
T0 and T1 and the difference at T1 between the intervention and
control groups, independent sample t-tests were used, because
National ROM Quality Improvement Collaborative
Observational study
14 control
teams
6
control
teams
6
intervention
teams
RCT
Matched pairs
21 intervention 
teams
Fig. 1 Parallel group design with nested randomised controlled trial (RCT). ROM, routine outcome monitoring.
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clinicians of the participating teams, who filled out the survey at T0
and T1, were not always the same. Mean, standard deviation,
confidence intervals and effect sizes were computed. The effect sizes
were calculated by the following formula: Mpost−Mpre/SDpooled
(because of independent groups).
SDpooled=√ ((SD12+SD22)/2) using the effect size calculator
for separate groups of L. Becker, University of Colorado (www.
uccs.edu/lbecker/index.html). The thresholds for interpreting the
effect size were small (0.00–0.32), medium (0.33–0.55) and large
(0.56–1.20).26 We repeated the analysis described above for the
randomised teams (the nested RCT). Finally, in the intervention
group of the parallel group design we looked at the differences
between three main groups of clinicians (physicians, psychologists
and nurses). Independent sample t-tests were used to calculate
differences between T0 and T1 for each group of clinicians
separately. Differences between the groups of clinicians on T0
and T1 were tested with analysis of variance (ANOVA) and post
hoc tests (Bonferroni).
Power calculation
This study was designed to detect, in the intervention teams of
the parallel group design, a medium effect size of d=0.5 on the
primary outcome ‘actual use and the perceived clinical utility of
ROM in clinical practice’ comparing T1 with T0. With α=0.05 and
a power β=0.80, the required sample size was 65 clinicians in the
intervention group.27
Results
In each paragraph, the results are first described for the total
parallel group design and next for the nested randomised design.
Putative differences in effects among types of clinicians are shown
for the parallel group design.
Participants
Parallel group design
Twenty-one teams from organisations of specialised mental
healthcare across the country participated (see Fig. 2, flowchart
2a). In 14 of them, two similar teams were included. Flowchart
2a shows that, during the Collaborative, three teams dropped out
between T0 and T1, mainly because of reorganisations and
personnel changes in the participating teams.
At T0, 69% of the clinicians in the intervention group and
75% in the control group responded to the survey. The types of
clinicians responding to the survey in terms of profession were 11%
physicians, 53% psychologists and 36% nurses in the intervention
group, and 21% physicians, 43% psychologists and 36% nurses in
the control group. The composition between intervention and
control teams did not differ significantly.
At T1, 89% of the clinicians in the intervention group and 62%
in the control group responded to the survey. The composition of
the clinicians responding to the survey was 25% physicians, 44%
psychologists and 31% nurses in the intervention group, and 17%
physicians, 40% psychologists and 43% nurses in the control
group. As with T0, the differences in composition at T1 between
intervention and control groups were not significant.
Cluster randomised control design
In Fig. 2, flowchart 2b shows loss of data over time in the
randomised teams. In total, clinicians of six intervention teams
and six control teams filled out the survey. Between T0 and T1, one
team dropped out because of reorganisation and personnel changes.
At T0, 73% of the clinicians in the intervention group and 83% in
the control group responded to the survey. The composition of the
group of clinicians responding to the survey in terms of profession
was 0% physicians, 65% psychologists and 35% nurses in the
intervention teams, and 13% physicians, 67% psychologists and
20% nurses in the control teams.
At T1, 73% of the clinicians in the intervention group and
75% in the control group responded to the survey. At T1, the com‐
position of these groups of clinicians responding to the survey was
9% physicians, 58% psychologists and 33% nurses in the interven-
tion group, and 0% physicians, 54% psychologists and 46% nurses
in the control group. Both at T0 and T1, there were no significant
differences in the composition of clinicians between intervention
and control groups.
Results of the survey
To demonstrate the changes in the actual use and perceived clinical
utility of ROM in the teams which participated in the Collabora-
tive, first the difference between first (T0) and final measurements
(T1) of the intervention group is described. Second, we looked at
the differences between intervention and control groups at the end
of the Collaborative (T1). The results are demonstrated for both the
parallel groups as the nested randomised design.
T
0
 (before start project)
21 intervention and 14 control
Completed by:
91 intervention clinicians = 69% response
34 control clinicians = 57% response
Dropped out: 6 teams
(3 intervention, 3 control)
T
1
 (at the end, after 1 year)
18 intervention and 11 control.
Completed by:
79 intervention clinicians = 89% response 
32 control clinicians = 62% response
T
0
 (before start project)
6 intervention, 6 control teams
Completed by:
19 intervention clinicians = 73% response 
15 control clinicians = 83% response
Dropped out: 2 teams
(1 intervention, 1 control)
T
1
 (at the end, after 1 year)
5 intervention, 5 control teams
Completed by:
19 intervention clinicians = 73% response
15 control clinicians = 75% response
Parallel group design (2a) RCT design (2b)
Fig. 2 Flow chart parallel group design (ﬂowchart 2a) and randomised controlled trial (RCT) design (ﬂowchart 2b).
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Differences between first and final measurements of the intervention
group
Parallel group design In the intervention group, significant
positive differences were shown between T0 and T1 on the
total scale and all subscales of the survey ‘ROM in daily practice’
with medium to large effect sizes (between 0.55 and 1.02,
with an effect size of 0.99 on the total scale) (Table 1). The
control group showed no significant differences between T0
and T1.
Cluster randomised control design The randomised group
showed comparable results in the application of ROM in daily
practice (Table 1). The effect sizes in the randomised intervention
group were even larger (between 0.97 and 1.25, with an effect size
of 1.25 on the total scale) than in the intervention group of the
parallel group design (Table 1). Also in this design, the control
group showed no significant differences between first and final
measurements.
Differences in final measurements between intervention and control
group
Parallel group design When the differences in T1 between the
intervention and control groups were tested, the final measure-
ment of the intervention group scored significantly higher than
the control group (Table 2). This means that at the end of the
improvement year, ROM in daily practice is better implemented
and used in clinical practice by respondents in the intervention
group compared with respondents in the control group.
Cluster randomised control design While comparing the final
measurements (T1), the above-mentioned positive significant
results in favour of the intervention teams were also shown in the
RCT (Table 2).
Differences between clinicians
When comparing the first and final measurements in the interven-
tion group of the parallel group design (Table 3), nurses and
psychologists in the intervention group demonstrated at T1 a
significantly higher score on all the survey domains with large
effect sizes (nurses between 0.68 and 1.28; psychologists between
0.57 and 1.17). Physicians in the intervention group scored at T1,
compared with T0, significantly higher on the total score and the
subdomain ‘Use of ROM in the team and organisational precondi-
tions’, with large effect sizes on these scales (1.51 and 0.97). The
three groups of clinicians participating in the control group showed
no significant increase of T1 relative to T0.
At T0, compared with the psychologists of the intervention
group, nurses of this group showed a significantly lower score
on the domain ‘Accessibility ROM for patient and clinician’
(P=0.006 and CI=−1.020 to −0.134). During the Collaborative
year, the differences between these groups of clinicians were
reduced. At T1, no significant differences were shown between the
groups of clinicians in the intervention group.
Discussion
This paper presents the findings from the government-sponsored
National QIC aimed to accelerate the implementation of ROM in
Table 1 Changes in the intervention teams: T1 compared with T0 in parallel group design and nested RCT
Parallel group design intervention teams Cluster randomised control trial intervention teams
Effect Sig.
95% CI of
the difference Effect Sig.
95% CI of
the difference
Survey domains N Mean s.d. size t-tailed Lower Upper N Mean s.d. size t-tailed Lower Upper
Individual use and perceived T0 91 3.28 1.01 0.62 0.000 −0.84 −0.29 19 3.22 1.07 1.11 0.002 −1.47 −0.36
utility of ROM in daily practice T1 79 3.84 0.80 19 4.14 0.47
Use of ROM in the team and T0 91 2.59 0.85 1.02 0.000 −1.05 −0.57 19 2.59 0.80 1.14 0.001 −1.36 −0.37
organisational preconditions T1 79 3.40 0.74 19 3.45 0.71
Usefulness of the ROM T0 91 2.95 0.85 0.55 0.000 −0.77 −0.22 19 3.07 0.96 0.97 0.005 −1.35 −0.26
questionnaires T1 79 3.45 0.95 19 3.87 0.68
Accessibility ROM for T0 91 2.95 0.72 0.88 0.000 −0.86 −0.42 19 2.96 0.97 1.07 0.002 −1.39 −0.33
patient and clinician T1 79 3.59 0.74 19 3.82 0.59
Total score of the ROM T0 91 2.94 0.64 0.99 0.000 −0.82 −0.43 19 2.96 0.83 1.25 0.000 −1.31 −0.41
in daily practice T1 79 3.57 0.63 19 3.82 0.51
CI, confidence interval; RCT, randomised controlled trial; ROM, routine outcome monitoring; Sig., significance.
Table 2 Differences between intervention and control groups at T1 in parallel group design and nested RCT
Parallel group design T1 intervention and control Cluster randomised control trial T1 intervention and control
95% CI of
the difference
95% CI
of the difference
Survey domains N Mean T2 s.d. Sig. t-tailed Lower Upper N Mean T2 s.d. Sig. t-tailed Lower Upper
Individual use and perceived I 79 3.84 0.80 0.000 0.52 1.20 19 4.14 0.47 0.000 0.74 1.72
utility of ROM in daily practice C 32 2.98 0.87 15 2.91 0.81
Use of ROM in the team and I 79 3.40 0.74 0.000 0.44 1.08 19 3.45 0.71 0.005 0.24 1.25
organisational preconditions C 32 2.64 0.86 15 2.70 0.74
Usefulness of the ROM I 79 3.45 0.95 0.008 0.15 0.95 19 3.87 0.68 0.011 0.19 1.32
questionnaires C 32 2.90 0.99 15 3.12 0.94
Accessibility ROM for I 79 3.59 0.74 0.000 0.28 0.94 19 3.82 0.59 0.001 0.45 1.55
patient and clinician C 32 2.98 0.92 15 2.82 0.97
Total score of the ROM in I 79 3.57 0.63 0.000 0.42 0.97 19 3.82 0.51 0.000 0.50 1.36
daily practice C 32 2.88 0.73 15 2.89 0.72
C, control group; CI, confidence interval; I, intervention; RCT, randomised controlled trial; ROM, routine outcome monitoring; Sig., significance.
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Dutch-specialised mental healthcare. The study included a
parallel group design with matched pairs of participating teams,
in which a cluster RCT was nested. In both intervention and
control teams, the actual use of ROM in routine clinical
practice and the perceived clinical utility of outcome measure-
ments were investigated at the beginning and end of the
Collaborative.
In both the parallel group design and the nested RCT, the
intervention teams reported much better results with respect to
the actual use and the perceived clinical utility of ROM (Tables 1
and 2). In the parallel group design, which included 21 interven-
tion teams across the country, the overall effect was large (d=0.99).
Notably, the effect size in the nested RCT was even bigger (d=1.25)
than in the study with the parallel groups. This is probably
because of the more rigorous research design and implementation
protocol that was used in the RCT. Considering putative differ-
ences among specific groups of clinicians, psychologists and nurses
participating in the intervention group demonstrated a large
improvement on both the overall scale and all the subdomains,
measuring different aspects of ROM implementation. The physi-
cians taking part in the study showed a similar large improvement
in the overall scale. Looking at the specific subscales, their
improvement was restricted to the domain ‘Use of ROM in
the team and organisational preconditions’. This may be explained
by the tasks physicians have in the teams, which are less focused
on the execution of the ROM measures and more on the team
supervision and organisation of care. Their assessments of the
usefulness of ROM may have been more driven by the ROM-
related activities they noticed in the team, represented by the
subscale ‘Use of ROM in the team and organisational precondi-
tions’. The other three subdomains showed practical and executive
functions in the application of ROM. The baseline difference
among psychologists and nurses on the subdomain ‘Accessibility
ROM for patient and clinician’ might be related to the background
of psychologists who are generally more inclined to use measure-
ment instruments in daily practice. It is encouraging to see that
this targeted intervention succeeded in reducing the difference
between psychologists and nurses, implying that the intervention
was successful in engaging nursing personnel in this area that
is so important for their work.
Strengths
In this study, we had the unique opportunity to nest a rigorous
experimental study (RCT) design within a government-sponsored
national initiative to improve mental healthcare. We built on
previous work in which the survey was developed.24 The teams
experienced ownership of their improvement process and were
facilitated by the National QIC. A variety of teams with a multi‐
disciplinary composition of clinicians treating different patient
groups (age, diagnoses and setting) participated in the study.
Independent data collection took place by a data management
team, which processed the results anonymously. Thus, the
likelihood of socially desirable answers and influence of the
research team on the results were diminished. To prevent possible
influence of confounding, the results were shown for both the
parallel group design and the nested cluster randomised design
separately. Strength of the parallel group design was the large
external validity because of the number and variation of the
participating teams. The randomised group included fewer
teams, but the risk of confounding was reduced, and in this
design, we conducted a strict research and implementation
protocol.
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Limitations
The study also had some limitations which may have influenced
the results. First, the clinicians were aware of the objective of the
National Collaborative, which may have affected their answers on
the survey. Second, there may have been cross-over effects of
knowledge and experiences from the intervention to control group.
Third, the survey could be seen as a process evaluation, focusing on
the implementation of ROM seen by clinicians who participated in
the Collaborative. To get insight in the experiences of patients and
the effectiveness of the intervention at patient level, an additional
study is underway, which will research the effects on decisional
conflict of patients, working alliance, treatment adherence, clinical
outcome and quality of live.20 Finally, the follow-up is restricted,
and it is unknown how the teams fared with ROM over a longer
time. Given the large effect sizes between the final and first
measurements and the attention that was given during the
Collaborative to the continuity of the implementation afterwards,
we expect the intervention teams will maintain the positive effects
of the Collaborative. Nevertheless, it is still important to ensure
that the teams continue the intervention by organising follow-up
and booster sessions.
Given the above limitations, our overall conclusion is that
the implementation of outcome measurement in clinical practice
was highly successful and appreciated by the multidisciplinary
teams that were involved. All the three groups of clinicians
participating in the intervention group take advantage of the
ROM implementation and showed, at the end of the Collaborative,
an equal level in the actual use and the perceived utility of ROM
in clinical practice. Successful in the ROM implementation is
the bottom-up approach, in which multidisciplinary teams were
facilitated to complete their own improvement cycle. This study is
unique in that we combined a National Collaborative of Quality
Improvement in mental healthcare with an evaluation study in
two designs, a parallel group design and a nested RCT. The results
have both internal (with regard to the rigorous design and
implementation) and external (given the nationwide implementa-
tion and evaluation) validity. Given the established advantages of
MBC and the difficulties previously encountered in implementing
the use of ROM in routine care, these results are encouraging and
call for more implementation efforts along these lines.
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